Collaborative peri-transplant management of volume status, hypertension, and immunosuppression: enhancing kidney transplants for better outcomes

Ren Fail. 2023;45(2):2271559. doi: 10.1080/0886022X.2023.2271559. Epub 2023 Oct 27.

Amy Perry¹, Prince Anand Mohan², Kevin Bodker³, Mohamed Elshennawy⁴, David J Taber^{1

3}, Johann Herberth¹, Karim Soliman^{1

3

5}

¹ Medical Services, Ralph H. Johnson VA Medical Center, Charleston, SC, USA.
² Department of Medicine, Division of Transplant Surgery, Medical University of South Carolina, Lancaster, SC, USA.
³ Department of Medicine, Division of Nephrology, Medical University of South Carolina, Charleston, SC, USA.
⁴ Department of Medicine, Al-Azhar University, Asyut, Egypt.
⁵ Department of Surgery, Division of Transplant Surgery, Medical University of South Carolina, Charleston, SC, USA.

No abstract available

MeSH terms

Dr. Taber has Research Grants from Veloxis, Merck, CareDx and is an Advisory Board Member for Veloxis, CareDx, Eurofins.